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Abstract  
Ascorbate mobilizes iron from equine spleen ferritin by two separate processes. Ascorbate 
alone mobilizes ferritin iron with an apparent Km (ascorbate) ≈ 1.5 mM.  Labile iron > 2 μM, 
complexed with citrate (10 mM), synergises ascorbate-dependent iron mobilization by 
decreasing the apparent Km (ascorbate) to ≈ 270 μM and raising maximal mobilization rate by ≈ 5-
fold. Catalase reduces the apparent Km(ascorbate) for both ascorbate and ascorbate + iron 
dependent mobilization by ≈ 80%. Iron mobilization by ascorbate alone has a higher 
activation energy (Ea = 45.0 ± 5.5 kJ/mole) than when mediated by ascorbate with labile iron 
(10 μM) (Ea = 13.7 ± 2.2 kJ/mole); also mobilization by iron-ascorbate has a three-fold higher 
pH sensitivity (pH range 6.0-8.0) than with ascorbate alone. Hydrogen peroxide inhibits 
ascorbate’s iron mobilizing action.   
EPR and autochemiluminescence studies show that ascorbate and labile iron within ferritin 
enhances radical formation, whereas ascorbate alone produces negligible radicals. These 
findings suggest that iron catalysed single electron transfer reactions from ascorbate, 
involving ascorbate or superoxide and possibly ferroxidase tyrosine radicals, accelerate iron 
mobilization from the ferroxidase centre more than EPR silent, bi-dentate two-electron 
transfers. These differing modes of electron transference from ascorbate mirror the known 
mono and bidentate oxidation reactions of dioxygen and hydrogen peroxide with di-ferrous 
iron at the ferroxidase centre. This study implies that labile iron, at physiological pH, 
complexed with citrate, synergises iron mobilization from ferritin by ascorbate (50-4000 μM). 
This autocatalytic process can exacerbate oxidative stress in ferritin-containing inflamed 




Ascorbic acid, Asc; ascorbic acid oxidase, Asc Ox; ascorbate anion, AscH-; ascorbate dianion, 
Asc2-; ascorbyl radical, AscH•; ascorbate radical, AFR or Asc.-; catalase, Cat. ; 
chemiluminescence, CL; dehydroascorbate, DHA; electron paramagnetic resonance, EPR; 
ferritin heavy chain, FHC; ferritin light chain, FLC; ferroxidase centre, FOC; Michaelis Menten 
coefficients in mM and nmol mg-1 ferritin min-1, respectively, Km, Vmax (ascorbate); milliTesla, mT; 
3-(N-morpholine)propanesulfonic acid, MOPS; non-transferrin bound iron,  NTBI;   reactive 




Iron is an essential mineral required for synthesis of iron-containing proteins, including 
haemoglobin, myoglobin and cytochromes [1].  In a typical 70 kg adult human male, around   
30% of his total iron (6 g) is sequestered in ferritin.  Free “labile” iron activity within body 
fluids is normally very low and present mainly as hydrated complexes in proteins, such as 
albumin, or as low molecular weight chelates with citrate or glutathione [2]. In the plasma of 
patients suffering from iron overload, the amount of redox active and chelatable non-
transferrin bound iron (NTBI) is in the range of 1-20 µM  [3–5]. Ascorbic acid is highly 
concentrated in a few tissues, e.g. brain, adrenal glands, and cartilage, [6] but low in others,  
e.g. liver and pancreas [7]. Under these circumstances, a complex tissue-differentiated 
regulation of the iron storage/release from ferritin must be considered. 
Ferritin is a multimeric iron storage protein consisting of a mixture of 24 heavy (FHC) and light 
(FLC) polypeptide chains with combined weights of 474 kDa that form a spherical shell with 
the capacity to store oxidised ferric iron. Only the FHC chains possess ferroxidase activity (i.e. 
the capacity to catalyse oxidation of Fe(II) to Fe(III)); FLC-rich ferritins, such as equine spleen 
ferritin, have slower iron oxidation rates, but promote nucleation and storage of ferric iron 
into the ferritin core [8].   The numbers of iron ions stored as crystalline solid per ferritin cage 
normally vary from 500 to 2500.  In iron-overload conditions, this number can reach 3000 to 
4000 [9] .  
Nonpolar channels, predominantly lined with leucine lie within the six four-fold subunit 
intersections of the ferritin shell [10,11]; whereas hydrophilic channels, lined predominately 
with anionic aspartate and glutamate side-chains, are present in all eight of the three-subunit 
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intersections. Ferrous iron Fe(II) enters and leaves ferritin through these 3-fold hydrophilic 
channels and a gateway iron binding site at the channel entrance [12] Iron(II) entry via the 
threefold channels can be blocked by Zn(II) [13]. 
 Iron uptake into ferritin via multiple oxidation processes.  
The initial reaction of ferrous iron with ferritin involves dioxygen reacting with two vicinally 
bound ferrous ions at the ferroxidase centre (FOC), present only in FHC, in a sequential 
electron transfer process to reduce dioxygen to hydrogen peroxide [14–16] to produce 
diferric-peroxo precursor (2FeOOH), protons and hydrogen peroxide (Equations 1 and 2) and 
then to the diferric oxo product. Similar processes occur in other members of the ferritin-like 
superfamily, e.g. ribonucleotide reductase, R2 proteins, where a di-iron ligand pair is bridged 
by glutamate carboxyl residues [17,18]. 
2Fe(II) -P + O2 + 2H
+ --> 2Fe(III) (O2) + 2H
+ ---> 2Fe(III)-P + H2O2                                                                     Eq 1    
where Fe(II)2-P represents the protein complex with iron [19,20] 
The unstable bridged oxy-diferric complex undergoes hydrolysis, which results in proton 
release and is the basis of the mineralization process. As iron loading proceeds, a higher 
proportion of oxygen from water takes part in the reaction and net hydrogen peroxide 
production is reduced to zero:  
4Fe(II)  + O2 + 6H2O → 4FeOOH-P + 8H
+                                                                        Eq 2 
At still higher iron loads,[11] hydrogen peroxide is consumed in a two-electron transfer 
reaction to convert the diferrous to diferric complex at the FHC, thereby consuming the 
potentially toxic hydrogen peroxide  
2Fe (II) + H2O2 + 2H2O → 2FeOOH-P  + 4H
+
                                                                                                     Eq 3 
This differs from the Fenton reaction in which water solvated ferrous iron is oxidised by 
hydrogen peroxide to produce ferric iron and hydroxyl radical.  
Fe(II) + H2O2 → Fe(III) + HO
• + OH- [21]                                                                             Eq 4 
 The one-electron reduction of O2 by Fe(II) produces superoxide [18] 
   Fe(II) + O2
   → Fe(III) + O2
•-                                                                                                                                                   Eq 5 
The sum of reactions in equation 4 and the reversed reaction in equation 5 [22] in aqueous 
solutions is termed the Haber-Weiss reaction [22,23] equation 6,  
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  H2O2 + O2
•-   
  (  )   (   )⁄
 
 > HO• + OH- + O2
                                                                       Eq 6   
This process is facilitated when ferric iron is chelated with citrate or adenine nucleotides or 
EDTA  [5]  and citrate is used as the iron buffer in all experiments described in this paper. At 
aqueous interfaces, the most favoured reaction appears to be a two-electron oxidation [24].   
Fe(II) + H2O2 → Fe(IV)O
2+ + H2O                                                                                              Eq 7 
Or  
Fe(II) + O3 → Fe(IV)O
2+ + O2                                                                                                                                                        Eq 8 
and this reaction may also occur within the ferritin core.    
It has been reported that ferric citrate complexes can auto-reduce and take part in redox 
cycling  [25].  
Release of iron from ferritin 
Although lysosomal proteolytic degradation of the ferritin shell with consequent iron release 
occurs  [26], this is an uncontrolled and potentially toxic process; normally, a more controlled 
mechanism is thought to occur [26,27].  Elucidating this buffering role by ferritin of 
cytoplasmic labile iron and reactive oxygen species (ROS) is the current priority. Iron 
mobilization from the ferritin core involves reduction of the insoluble ferric to soluble ferrous 
state. Electron transfer between the cytosol and the core is essential to this release process. 
The liberated core ferrous ions are hydrated, solubilised and exit via ferritin’s threefold polar 
channels with water [18]. Electron donors, such as superoxide (O2
•−) or ascorbate anion (AscH-
), or ascorbate radical, Asc•- (AFR) [28], may pass directly via the wall channels to the ferritin 
core to reduce iron by one-electron transfer [29–31]   
AscH- + Citrate-Fe(III) → Asc•- + Citrate-Fe(II) + H+                                                           Eq 9 
A subsequent one-electron reduction of ferric to ferrous iron and also producing 
dehydroascorbate (DHA) can be obtained by oxidation of AFR [4,23].   
Asc•- + Citrate-Fe(III) → DHA + Citrate-Fe(II)                                                                     Eq 10 
  An alternative mechanism may involve electron transference by tunnelling through the 
protein via an electron transport chain.  Haem, too large to pass into the ferritin via the pores, 
can act as an electron donor [29,32]. Electrons can also be transferred to ferritin by passing an 
electric current directly from electrodes [33]. 
-5- 
 
Effects of ascorbate: role of complexed metal ions in ascorbate oxidation  
The spontaneous rate of ascorbate oxidation  
Asc2-+ O2→ Asc
•-+ O2
•−                                                                                                                                                               Eq 11 
is slow (300 M-1 s-1), but in the presence of traces of iron or copper ascorbate oxidation is 
notoriously rapid [21,34,35]. Ascorbate can readily donate electrons to metal ions such as iron 
and copper[36–39]  as seen in equations 9 and 10.   
Ascorbate is generally considered as an efficient antioxidant of nearly every oxidizing radical, 
e.g.  R• + AscH-    → Asc•- + RH  [40] .                             
This reaction can be either retarded or accelerated by complexation with reagents such as 
desferrioxamine or citrate, respectively [23,41].    
The mechanisms by which combinations of metal ion, dioxygen, and ascorbate produce  
superoxide, hydrogen peroxide, and hydroxyl radicals  are contentious [21,37–39,42] . Metal 
ion catalysis of superoxide production results in extensive redox cycling when iron, oxygen, 
and ascorbate are together in solution, (see equations 5-11) [43]. The review paper by Frei 
and Lawson [37] indicates that metal ion-catalysed oxidation of ascorbate produces ascorbate 
radicals  as a consequence of the transient intermediate formation of superoxide radicals that 
disproportionate to hydrogen peroxide and dioxygen. In turn, the hydrogen peroxide formed 
can react with superoxide in the Haber-Weiss reaction (Equations 5 and 6) to produce 
hydroxyl radical and may be the basis of ascorbate’s observed pro-oxidant effect.   
These secondary reactions initiated by ascorbate, oxygen, and metal ions can be inhibited by  
superoxide dismutase and catalase and thereby can alter the rates of ferritin iron mobilization 
[44] .  
Many studies have shown that ascorbate increases the rate of iron release from ferritin by 
reducing core ferric to ferrous iron [45–47].    The apparent Km for this complex ascorbate-
dependent iron mobilization process from ferritin is in the range 1.5-2.0 mM  [44,47,48] .  In 
this paper the apparent Km (ascorbate ± Fe) refers to the half-maximal concentration at which 
ascorbate activates the entire iron mobilization process and thus may be affected by the local 
concentrations of competitors such as hydrogen peroxide or activators such as ascorbate 
radical.  This is apparent Km(ascorbate) is determine by non-linear least squares regression 
analysis of the entire data set using the Levenberg-Marquardt algorithm included with 
Kaleidagraph (Synergy Software.com). 
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However, ascorbate-dependent release of iron from ferritin is not considered to provide a 
major contribution to pathological oxidation reactions because its concentration is deemed 
generally to be too low to generate high iron mobilization rates [49] . Nevertheless, it is 
evident that labile iron has an important role in ascorbate-mediated iron mobilization from 
ferritin [44,50–53]. Our primary goal was to explore more thoroughly this potentially toxic 
relationship.   
Our second aim was to observe how hydrogen peroxide, superoxide, and ascorbate anion and 
radical affect rates of iron mobilization from ferritin [52,54–56] . Hydrogen peroxide acts as 
an oxidant for iron mineralisation and therefore retards iron mobilization [14,57].   
Interestingly hydrogen peroxide has been observed to stimulate ascorbate oxidation 
catalysed by copper ion [36].   This suggests that hydrogen peroxide has differing roles in 
ferritin iron and ascorbate oxidation in aqueous solution. 
Materials and Methods 
The following chemicals and enzymes were obtained from Sigma-Aldrich Chemical Co., UK. 
Superoxide dismutase (SOD) bovine recombinant, expressed in E. coli, lyophilized powder, 
≥2500 units/mg protein, thus 10 units/ml is equivalent to 4 µg SOD or 120 nM and 50 units 
/ml is equivalent to 600 nM.  Catalase (Cat. ), obtained as a lyophilized powder, 2000-5000 
units/mg, 60 kDa mol wt., i.e. catalase at 10 units.ml-1 is equivalent to 5 nM; ascorbic acid 
oxidase (Asc Ox) from Cucurbita sp., 1000-3000 unit/mg protein, mol wt. 70 kDa/monomer, 
i.e. 0.25 unit/ml ≡ 2 nM; xanthine oxidase (XO) from bovine milk and horse spleen ferritin in 
saline solution. Ferrozine iron (3-(2-pyridyl)-5, 6-diphenyl-1, 2, 4-triazine-4’, 4’’-disulfonic acid 
sodium salt reagent, hydrate) was obtained from Acros Organics – Fisher Scientific 
(www.fisher.co.uk).  Citric acid, hydrogen peroxide solution, ascorbic acid, ferrous sulphate, 
and zinc chloride were obtained from BDH Ltd, Dorset, UK.  All solutions were prepared 
freshly with double-distilled water.  
Determining effects of ferrozine in citrate MOPS buffered medium on iron mobilization from 
horse spleen ferritin.  
Ferrozine produces a strongly coloured complex with ferrous iron that is stable over normal 
physiological pH ranges [58]  . Ferrozine (75 µM) was added to a mixture containing final 
concentrations of horse-spleen ferritin (50 or 75 nM) diluted in NaCl (150 mM),  sodium 
citrate (10mM), ascorbic acid (Asc) (0-10 mM), 3-(N-morpholine)propanesulfonic acid MOPS 
(50 mM) buffer at pH 7.0 and varying concentrations of ferrous  iron (FeSO4).   Sodium citrate 
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(10 mM) gives stable Fe-buffering and reduces iron activity to approximately 3 orders lower 
than its nominal concentration. This permits iron release from ferritin to be monitored over 2-
3h. Reagents were added to Nunc 96-well plates (www.thermoscientific.com/en/about-us/) 
with final volumes of 100 µl per well and absorption was monitored at 550 nm with a 
Molecular Devices Spectra Max 190 plate reader (GMI-inc.com). All the presented data are 
means ± SEM shown as error bars. Each point is the average of triplicate or quadruplicate 
assays, Figure 2A. The linear and non-linear fits ± SEM to the data were obtained using the 
Levenberg-Marquardt algorithm included with Kaleidagraph (Synergy Software.com). 
 
 
EPR spectra of ascorbate ferritin solutions  
The EPR spectra of ascorbate free radical (AFR) were recorded with Bruker spectrometers 
(ER200D and Elexsys 500 (Bruker Spectrospin, Wissembourg, France)) operating at 9.85 GHz 
and equipped with a high-sensitivity cavity.  The ascorbate radical doublet (AH = 0.18 mT) is 
measured at g  2.00. Typical settings used were: microwave power, 10 mW; modulation 
frequency, 100 kHz; modulation amplitude, 0.2 mT; receiver gain, 60 dB; time-filter constant 
40.96 ms; conversion time, 41.04 ms; data points, 1024; sweep width, 0.8 mT; sweep time 
21.01 s. EPR spectra were recorded sequentially during the whole reaction at 24˚C. Data 
acquisition was performed using Bruker Xepr software, then analysed and presented using 
Microsoft Excel 2013 with Microsoft Chart 2013.  
The reagent solutions contained in a sealed sample cell comprised ascorbate, labile iron and 
equine spleen ferritin in citrate buffer (1 mM, pH 7.0). Spectra were recorded immediately 
after mixing with or without superoxide dismutase and/or catalase. When indicated, the 
ferritin solution was deoxygenated either by a cycle of vacuum-argon gas bubbling at room 
temperature before transferring to the sample cell, or with nitrogen flushed around gas 
permeable PTFE tubing (Extruded Sub-Lite-Wall, inside diameter 0.635 mm, wall thickness 
0.051 mm; Zeus Industrial Products, Ireland   [59]). 
The ascorbate radical concentration was estimated using coarse quantification of the EPR 
signal with 4-hydroxy-tetramethylpiperidin-1-oxyl (TEMPOL) as an external standard and 
accurate simulation of the individual spectra with the program developed by Rockenbauer 
and Korecz  [60].  
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Simulation of ascorbate radical reaction with ferritin. 
The rates of ascorbate radical production from ascorbate (250 M) with ascorbic acid oxidase 
(8 nM) and its disproportionation to ascorbate and dehydroascorbate and simultaneous 
reaction with varying concentrations of ferritin (0, 200 nM, and 500 nM) in citrate buffer pH 
7.0 at 24C were simulated using the differential equation modelling program Berkeley 
Madonna Jmadonna version 9 (http://www.berkeleymadonna.com/), see supplementary 
text.  The simulations were fitted to the observed EPR data by least square estimates using 
Excel Solver 2013 add-in and using the Levenberg-Marquardt algorithm included with 
Kaleidagraph (Synergy Software.com). 
 
Chemiluminescence (CL) studies.  
Solution samples in citrate buffer at pH 7.0 and 24˚C were prepared and luminescence 
monitored in a Perkin Elmer luminescence spectrometer, model LS50B with the excitation 
beam switched off. Chemiluminescence detection of radical products released from ferritin 
was performed with 500 nM ferritin and 0-25 µM FeSO4. Ascorbate was varied in a buffer 
solution of 50 mM MOPS and 10 mM citrate at pH 7.  
Data analysis:  Unpaired Student’s t-tests were used to obtain the statistical significance of 
comparisons.  All the data reported show results obtained from at least three independent 
sets of data in which each point is a replicate of at least three points.  Where multiple tests 
were done, Bonferroni’s correction was used.  Data displayed in graphs show means ± 
standard error of the means (S.E.M.). The effects of ascorbate, iron, and citrate on the latency 
of iron release from ferritin were analysed using two-way ANOVA.   
Results 
Study of ascorbate and labile iron on iron release from ferritin in vitro 
Ascorbate (0-10 mM) in buffer solution, as previously demonstrated [47,48,61]  , released iron 
from ferritin (Figure 1A). In the absence of ferritin, negligible changes in ferrozine absorbance 
were recorded over the time course of the assay.   
Release rates of iron from ferritin increase as ascorbate concentration increases from 0-10 
mM (apparent Km 1.4 ± 0.2 mM) (Figures 1B and 1C) [44,47,48].  Increasing buffer Fe(II) 
concentration increased the sensitivity of ascorbate-dependent iron release.  The apparent Km  
of ascorbate-dependent iron mobilization fell as a hyperbolic function of iron concentration 
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from 1.4 ± 0.2 mM with zero iron to ≈ 200 ± 20 μM with [FeSO4] = 10 μM.  The Vmax of 
ascorbate-dependent iron mobilization, with [ascorbate] = 10 mM, in citrate buffer 10 mM at 
pH 7.0, increased on raising [FeSO4] from 0 to 10 μM as an exponential function of [FeSO4]; 
the Vmax increased by approximately fivefold. 
The iron sensitivity of ferritin is controlled by the complexation with citrate. With citrate (10 
mM), iron activity is approximately 3 orders lower than its nominal solution concentration, i.e. 
for iron citrate  (10 M), the Fe(II) activity is  10 nM  [62] . Raising citrate to 20 mM 
substantially reduces the iron sensitivity of ferrozine to iron release (see supplement Figure 
S1A).   
Effects of pH change on ascorbate (10 mM) and iron (10 M) -dependent release of ferritin 
iron.  
Whilst changing buffer pH from 6.0 to 8.0, with zero ascorbate, there were negligible effects 
on ferritin iron release.  Also, Fe(II) 10 M, without ascorbate, had negligible effects on iron 
mobilization (Figure 2A).  With ascorbate (10 mM) present, there was a large pH-sensitive 
iron release rate.  Whilst with both 10 mM ascorbate and FeSO4 10 M present, iron release 
from ferritin was three-fold more sensitive to pH than with Ascorbate (10 mM) alone, (P< 
0.001 of both ascorbate and ascorbate + Fe effects).     
Effects of temperature change on ascorbate and iron-dependent release of ferritin iron  
Ferritin iron release was monitored at 4o, 24o and 37o C with Ascorbate (10 mM) ± FeSO4 10 
M. There was a 4-fold increase in the temperature coefficient of ferritin iron mobilization 
rate with FeSO4 10 M and Ascorbate (10 mM), compared with that of Ascorbate (10 mM) 
alone. The activation energy with ascorbate alone (Ea (ascorbate) = 45.0 ± 5.5 kJ/mole) is three-
fold higher than with ascorbate and iron together {Ea (ascorbate + Fe(II)) = 13.7 ± 2.2 kJ/mole, 
(P<0.01)} Figure 2B.  
Evidence of autocatalysis of ferritin iron mobilization by combined external ascorbate and 
iron. 
The synergistic iron and ascorbate activity in mobilizing ferritin iron implies that with 
ascorbate present, the mobilized iron, will further auto-catalyse ferritin iron mobilization. A 
longer latency prior to attaining a steady state rate of iron release is likely to be more evident 
with low ascorbate and iron concentrations.  This prediction is confirmed in Figures 3A and 
3B. Increasing either ascorbate with low iron (Fe(II) < 10 M) (P < 0.0001), or iron with low 
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ascorbate (P < 0.0001), reduce the latency period before mobilization rates are observed 
(Figure 3B).    Exposing ferritin to catalase abolished the latency (P < 0.01) (Figure 3C), 
indicating that endogenous hydrogen peroxide stabilizes the FOC iron.   
Effects of zinc on ascorbate-dependent iron release from ferritin.  
As mentioned in the introduction, Zn(II) blocks iron flow via the three-fold ferritin channels, 
[14] ; increasing Zn(II)Cl2 from 0 to 10 M decreased ascorbate-dependent release of iron 
from ferritin in the absence of external Fe(II). The I.C.50 of Zn(II) on the ascorbate-dependent 
iron release is 2.2 ± 0.4 M (Figure 4A). Additionally, Zn(II) 20 M fully blocks iron release 
stimulated by ascorbate (10 mM) + Fe(II) (35 M) (P < 0.001 (Figure 4B) that).  Both Zn(II) and 
iron(II) concentrations were raised to generate full activation and inhibition of iron 
mobilization.  This experiment demonstrates that iron released by ascorbate originates from   
the ferritin core, rather than from displacement from the ferritin’s external surface [63,64]  
Hydrogen peroxide promotes Fe(II) oxidation within ferritin 
Hydrogen peroxide (300 M) has been observed to inhibit ascorbate-dependent iron 
mobilization from ferritin by up to 40% [44] . The effects of hydrogen peroxide on iron 
mobilization, without interference from any concurrently generated superoxide were 
observed by addition of superoxide dismutase to the incubation solutions (see equations 5 
and 6).  Hydrogen peroxide has a much stronger inhibitory effect on ascorbate-dependent 
iron release in the conditions used here, than previously reported [24]. This inhibition is 
apparently non-competitive and follows sigmoid kinetics consistent with Hill coefficient n ≈ 3 
for exogenous hydrogen peroxide  0.1 mM (Figure 5A). In the absence of exogenous 
hydrogen peroxide, the Hill coefficient of ascorbate-dependent iron mobilization equals 1.   
Raising H2O2 from 0 to 0.25 mM reduced the Vmax of ascorbate-dependent iron mobilization 
by ≈ 4-fold i.e. 80% inhibition (P < 0.001) (Figure 5A).  Hydrogen peroxide also reduced the 
apparent affinity of ascorbate; apparent Km (ascorbate) increased from 1.8 ± 0.2 mM without 
added H2O2, to 6.2 ± 1.4 mM when H2O2 was raised to 0.25 mM (P < 0.01) (Figure 5A).   
Labile FeSO4 10 μM counteracts the inhibitory effect of hydrogen peroxide on ascorbate’s 
mobilizing activity on ferritin iron (Figure 5B); the   apparent Km  (ascorbate) on ferritin iron 
mobilization with H2O2 (0.25 mM) fell from 6.2 ± 1.4 mM, without iron (Figure 5A) to 2.1 ± 0.2 
mM (P < 0.015) with FeSO4 10 μM (Figure 5B).     Raised hydrogen peroxide also increased the 
Hill coefficient of ferritin iron mobilization with ascorbate and iron present from n=1 without 
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H2O2, to n=1.8 with hydrogen peroxide (0.25 mM), and to n=3.0 with hydrogen peroxide (1.0 
mM). 
Sigmoid kinetics have been reported for ferritin Fe(II) oxidation of  mutant forms of human H-
chain ferroxidase and nucleation sites of human mitochondrial ferritin [19,65]  .  Oxo-anions 
such as phosphate, arsenate, or vanadate have been implicated in sigmoidal kinetics of iron 
oxidation [66] .  An explanation for the sigmoid kinetics is that once the centre is saturated 
with iron,  deposition occurs at additional lower affinity sites to the ferroxidase centre [67].  It 
is possible that a similar explanation for the sigmoidal curves seen in Figures 5A and 5B is that 
hydrogen peroxide may differentially stabilize iron depending on the sites within the ferritin 
core.    
The inhibitory effects of hydrogen peroxide on ascorbate dependent ferritin iron mobilization   
with varying labile iron concentrations are corroborated in Figure 5C.  Raising iron(II) from 
zero to 5 μM increased the I.C.50 of hydrogen peroxide inhibition of ascorbate-dependent 
ferritin iron mobilization from 0.11 ± 0.03 mM to 0.8 ± 0.2 mM (P < 0.005).  These findings 
indicate that the previously reported small effect of H2O2 on ascorbate-dependent ferritin 
iron mobilization might have been due to trace metal contamination [24] . 
Thus, labile iron increased the apparent efficacy of ascorbate as a mobilizer of ferritin iron, 
Figures 1B and 1C, whilst reducing the efficacy of H2O2 as a stabilizer of iron within the 
ferroxidase centre (Figure 5C). An explanation for both these phenomena is that the presence 
of labile iron prevents the bidentate competitive interactions of ascorbate and hydrogen 
peroxide with di-iron at the ferroxidase centre (see Discussion, Graphic, and Figure 6A).  
 Ascorbate-dependent iron mobilization from ferritin by superoxide.  
Superoxide dismutase is expected to suppress the influence of superoxide anion on redox 
cycling of Fe(II/III) catalysed by ferritin. The effects of ascorbate (0-20 mM) together with SOD   
(600 nM) are shown in Figure 5A, or with ascorbate (0-20 mM) and Fe(II) (10 μM) in Figure 
5B, or with varying SOD (0-120 nM) in Figure 7A.   SOD was added was to discriminate 
between potential effects of superoxide from those more specifically due to ascorbate-
dependent iron release from ferritin, (see equations 5, 6, 11).      
The ascorbate-dependent apparent Km of iron release was unaffected with superoxide 
dismutase (SOD) (600 nM) present, apparent Km 1.8 ± 0.2 mM (Figure 5A, continuous line, 
open circles), compared with zero SOD (Figure 1B). Similarly there was no significant effect on 
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the apparent Km (ascorbate+ Fe(II)) of iron mobilization (250 ± 30 M) with SOD (120 nM) (Figure 5B 
continuous line, open circles) compared to the apparent Km (ascorbate+ Fe(II)) =  200 ± 20 M with 
zero SOD (Figure 1B).  It may be deduced from these results that any superoxide production 
by ascorbate interactions with ferritin or iron does not alter the apparent Km  (ascorbate) of 
ferritin iron mobilization, either in the absence or presence of FeSO4 10 µM.  
Superoxide dismutase (SOD) caused a concentration-dependent inhibition of ascorbate-
dependent iron release from ferritin, as has been previously observed [42]   (Figure 7A).  With 
ascorbate (10 mM), the SOD-dependent fractional inhibition of iron mobilization from ferritin 
i.e. {rate of iron release with varying concentrations of SOD/rate of iron release without SOD} 
was reduced as FeSO4 concentration was raised from zero. With FeSO4 (1 µM), SOD (120 nM) 
reduced ascorbate (10 mM)-dependent ferritin iron mobilization by 55%, whereas with FeSO4 
(10 M), SOD (120 nM) reduced ferritin iron mobilization only by 15% (P < 0.005).     This 
indicates that the combination of Fe(II) (10 M) + ascorbate (10 mM) is a SOD-insensitive 
ferritin iron mobilizing factor.    
The effects of superoxide produced by oxidation of xanthine by xanthine oxidase on ascorbate 
± FeSO4 10 µM mobilization of ferritin iron.   
Superoxide generated by xanthine oxidase oxidation of xanthine or hypoxanthine is known to 
mobilize ferritin iron [45,53,68] ]. To test whether the apparent loss of SOD efficacy as an 
inhibitor of ascorbate-dependent ferritin iron mobilization with raised labile iron 
concentration is due to incomplete superoxide eradication, or to another species of free 
radical capable of mobilizing ferritin iron, xanthine oxidase (XO) generated effects were 
examined.  XO activity with ascorbate (1 mM) alone increased iron mobilization rates by 100% 
(P < 0.01) (Figure 7C). Xanthine oxidase had a relatively smaller effect on iron mobilization by 
ascorbate (1 mM) + FeSO4 (10 µM), (16% increase, P < 0.05).   
The smaller relative increase in iron mobilization by ascorbate (1 mM) + FeSO4 (10 µM)   
suggests that superoxide is already being generated by this combination and that at least one 
additional factor besides superoxide contributes to the higher rate iron mobilization. The 
larger relative increase in mobilization rate with ascorbate alone suggests nevertheless that 
superoxide is an important component to iron mobilization.  
Effect of catalase on ascorbate and iron dependent iron mobilization from ferritin 
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Catalase catalyses two-electron disproportionation of hydrogen peroxide to water and oxygen 
and has been observed previously to increase slightly the rate of ferritin iron mobilization by 
superoxide generated   by xanthine oxidase  [69] .  Here too it is shown that catalase (5 nM) 
enhances iron-ascorbate-dependent ferritin iron mobilization without apparently affecting 
iron mobilization by ascorbate alone (Figure 7B). This finding indicates that hydrogen 
peroxide produced mainly by iron and oxygen interaction with ferritin (Equation 1) retards 
ascorbate and iron-dependent ferritin iron mobilization (Figure 3C), as has already been 
demonstrated with exogenously added hydrogen peroxide (Figure 5C).  
 Catalase (10 nM) effects on ascorbate-dependent iron mobilization were further 
investigated.  Catalase reduced the apparent Km (ascorbate) of ferritin iron mobilization from 
control 1.2 ± 0.14 mM to 260 ± 30 M (P< 0.001) without affecting the Vmax (catalase) = 10.9 ± 0.3 
and Vmax (control) = 9.8 ± 0.3 nmoles min
-1 mg-1 ferritin (Figure 8A).  Similarly, catalase reduced 
the apparent Km  of ascorbate + Fe (10 M)-dependent ferritin iron mobilization from 390 
± 31 M to 77.6 ± 10.5 M (P< 0.001) (two-tailed Student’s n= 12 independent assays per 
point, two experiments), without significantly altering Vmax (control rate 65 ± 2; catalase rate 
60 ± 2 nmoles min-1 mg-1 ferritin) (Figure 8B).  
These results signify that ferritin’s ferroxidase centre is shielded from the reducing activity of 
low ascorbate concentrations ≤ 1 mM by endogenous hydrogen peroxide.  They also indicate 
that the estimates activation energy difference and the pH sensitivity difference between 
Ascorbate (10 mM) ± FeSO4 10 M (Figures 2A and 2B) will be unaltered by endogenous 
hydrogen peroxide concentrations, as the of ascorbate-dependent ferritin iron mobilization 
apparent Km s are 10-50 fold below the ascorbate (10 mM) used in these experiments.   
Ascorbic acid oxidase increases iron release 
 XO, in addition to generating superoxide, also produces hydroxyl radical, uric acid, a radical 
scavenger, and urate (uric acid) radical. [70,71]. These other reaction products create 
ambiguities in interpreting the role of XO in inducing iron mobilization from ferritin 
[44,53,61]. To reduce this uncertainty, the effect of ascorbic acid oxidase (Asc Ox), which 
produces ascorbate free radical (Asc·-) directly from ascorbate [72], was examined. As the 
ascorbyl radical (AscH.)/ascorbate radical (Asc.-) couple has a pKa of -0.86, the deprotonated 
form, ascorbate radical, predominates at neutral pH (Figure 6B) [38].  Asc Ox (2 nM), with 
ascorbate 1 mM and both SOD (120 nM) and catalase (5 nM) added to avoid contamination 
from extraneous superoxide and hydroxyl radical, increased the rate of iron mobilization by 
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approximately 100% (P <0.001) (Figure 9A). These results support the view that in addition to 
ascorbate anion, ascorbate radical is also a potent agent of single electron ferritin iron 
release. Ascorbic acid oxidase (1 nM) reduced apparent Km ascorbate of ascorbate-dependent 
iron release from 1.52 ± 0.52 mM (without Asc Ox) to 0.59 ± 0.13 mM (P < 0.01) (Figure 9B). 
This finding supports the view that single electron transfer reactions from ascorbate radical 
can mobilize ferritin iron more readily and with a much lower apparent Km ≈ (200-500 µM) 
than ascorbate alone (1.5-2.0 mM), (see Discussion).  
Ferritin ascorbate interactions monitored with chemiluminescence  
Much controversy exists as to the chemical species monitored by the chemiluminescence 
reporters Lucigenin [73–75]  and L-012, a Luminol derivative  [76–78]. To circumvent the 
ambiguities ascribed to luminescence reporters, which may themselves generate redox 
reactions, the effects of ascorbate and iron on ferritin-generated autochemiluminescence 
signals (CL) were used. The signal is optimal in the blue-green colour range of the spectrum 
(490 nm), as shown in Figures 10.  
In the absence of ferritin, background autochemiluminescence is negligible. Ferritin prolongs   
CL, so the signals were observed for periods of 20-30 minutes in citrate buffer at pH 7.0.  No 
CL signal was obtained with ferritin in the absence of ascorbate. Ascorbate alone with ferritin 
(500 nM) generated only a small CL signal increasing steadily with ascorbate (0.1-10 mM) 
(Figure 10C).  The maximal luminescence emission peak occurred at 470 nm (Figure 10A).  
Addition of iron(II) greatly enhanced the CL signal.  With ferritin and ascorbate + FeSO4 (25 
M), the optimal CL signal is between 470-490 nm. Increasing above ascorbate (100 M) with 
ferritin (500 nM) and FeSO4 (25 M) reduced the CL signal to approximately 50% of maximum 
with ascorbate in the concentration range > 250 M (Figure 10C). Catalase alone, or together 
with SOD, enhanced the optimal CL signal of iron + ascorbate + ferritin by approximately 50% 
(Figure 10D).  The finding that both catalase alone or in combination with SOD enhances the 
CL signal, suggests that hydrogen peroxide produced by ascorbate and iron interaction with 
ferritin suppresses CL, as it does for iron mobilization (Figures 5C). EPR signals of ascorbate 
iron ferritin interactions.  
EPR methodologies are commonly regarded as the “gold standard” for detection of radicals in 
biological systems[79,80]. To be detectable by EPR, short-lived superoxide and hydroxyl 
radical require spin traps and like chemiluminescence reporters, EPR spin trap radical adducts 
may   produce falsely negative results; they may be subject to reducing agents   [79]  and are 
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often unstable [81].  However unlike chemiluninescence reporters do not generate false 
positive signals.  No spin traps were used here to observe catalysis of ascorbate radical 
formation, as long-lived ascorbate radicals are readily detected by EPR without spin traps, and 
its reaction with ferritin at room temperature  [[47,82] .   
Steady state ascorbate radical concentration is dependent on  its formation by ascorbate 
oxidation in the presence of dioxygen, as catalyzed by free iron, or copper ions [32,80]   
chelated with citrate [2,3,23,42]  ; or by the action of ascorbic acid oxidase [83,84]  (see 
equations 10 and 11).  Its decay rate depends  both on availability of electron acceptors, such 
as ferritin  and its disproportionation reaction as a second order function of ascorbate radical 
concentration.  , equation 12, [42,72,84,85] .   
H+ + 2Asc-• → AscH-+ DHA                                                                                                 Eq 12 
Electrons donated by either AscH- or Asc-• can reduce ferritin iron [86]. With ferritin present 
there are possible radical electron transfer from both AscH- and Asc-• as follows (See graphic).  
AscH- + Fe(III)-P → Asc-•    + H+ + Fe(II)-P                                                                        Eq 13A 
Asc-•    + Fe(III)-P→ DHA + Fe(II)-P                                                                                    Eq 13B 
The EPR ascorbate radical signal with iron (10 M) increases by tenfold following addition of 
ferritin, from approximately 5 nM to 50 nM (Figure 11A). Thus, approximately 90% of the 
ascorbate radical EPR signal in the ferritin-ascorbate iron citrate pH 7.0 solution is generated 
by the additional presence of ferritin. The results shown here demonstrate that free iron 
increases the ferritin-induced ascorbate-radical signal as a linear function of iron (P < 0.001) 
(Figure 11C). The ascorbate radical signal has a t½ of   40 min with ascorbate 250 M, FeSO4 
(10 M), and 500 nM ferritin (not shown).  The relatively long half-life of this reaction is due in 
part to the slow disproportionation rate of ascorbate radical (Equation 12) that results in 
partial ascorbate regeneration. 
Raising the initial ascorbate concentration from 0-1000 M with ferritin (500 nM) and FeSO4 
(20 M) increases (P < 0.001) ascorbate free radical concentration from zero to 120 nM as a 
hyperbolic function of ascorbate with a small linear component (Figure 11E).       
As has been previously observed [86] , superoxide dismutase (120 nM) reduces the AFR signal   
(P < 0.01) and anoxic conditions almost completely abolish the AFR signal (Figure 11D).     
Interactions between ferritin and ascorbate radical.  
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Ferritin’s reactivity with ascorbate radical was determined by observing the altered rates of 
ascorbate radical decrease [87] . High ascorbate radical concentrations were produced by 
ascorbic acid oxidase (1 unit ml-1 ≡ 8 nM) acting on ascorbate (250 µM) in citrate (1 mM) 
buffer pH 7.0 at 24˚C.  The ascorbate radical signal initially increased at a rate dependent on 
ascorbate oxidase conversion of ascorbate to ascorbate radical.  However, this is increase is 
too rapid to be captured by the protocols used in (Figures 12A, 12B).  Loss of ascorbate 
radical is dependent on the combined rate of ferritin-induced AFR signal decay, which 
increases as a linear function of horse spleen ferritin concentration (Figure 12C), and of AFR 
disproportionation  (5x105 M-1 s-1) measured at 37C, pH 7.4 [23].      The data are consistent 
with a large second order rate constant of ascorbate radical reaction with ferritin (k = 1.2x107 
M-1 s-1).  This increases the rate of ascorbate radical loss. Addition of iron also increased the 
overall rate of ascorbate radical decrease with ferritin (200 nM) (Figure 12D).   
Discussion.  
Ascorbate-dependent iron release is potentiated by external iron 
The following discussion aims to interpret the results reported here in terms of mono- and di-
electron transfers to diferric iron 2Fe(III) at the ferroxidase centre of ferritin. The reduction of 
FOC2Fe(III) is taken as the limiting step for iron release from ferritin.  The redox potential Em is 
assumed to consist of several stepwise redox reaction, Em = [{Fe(III)−Fe(III)}/{Fe(III)−Fe(II)}]= 
+210 mV and Em  [{Fe(III)−Fe(II)}/{Fe(II)−Fe(II)}] = +50 mV;   a metastable Fe(III) in the 
ferroxidase centre mediates electrons transference from an external reducing agent to the 
Fe(III) in the mineral core [88].  
One electron transfers  
This study corroborates previous work showing that ascorbate increases the rate of iron 
mobilization from ferritin (apparent Km  (ascorbate) ≈ 1.5 mM, pH range 6-8)[46,47,61]. The main 
findings uncovered are that the rate of iron release from ferritin is synergised by the presence 
of pathophysiological concentrations of both labile iron (2.5-25 M) and ascorbate (50-250 
M) and that the chemical mechanism of this synergism differs from that induced solely by 
ascorbate.  The difference between the two mechanisms of mobilization is apparently related 
to the dissimilar processes controlling one and two electron transfer reactions to oxo-bridged 
di-iron at the ferroxidase centre in the ferritin core.    
Superoxide radical  
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Superoxide is a well-documented agent of single electron iron release from ferritin [46,93]. 
However, nominally “superoxide-induced” mobilization of ferritin iron is incompletely 
inhibited by SOD [[44,53,89]   as confirmed in (Figure 7A).   Superoxide generated by xanthine 
oxidase/xanthine (XO/X) has previously been observed to release iron from ferritin [53,90–
92].  Doubts have been expressed as to whether superoxide is the principal agent of single 
electron transference and reduction of the ferritin core iron [53].   Iron mobilization by 
superoxide on its own is a rather slow process [38]. This is ascribed to its relatively low redox 
potential  E O2/O
- -180mV, close to that of Fe(III/II) within the ferroxidase centre [93,94] .    
Ascorbate and ascorbate radical.   
One electron transfers by iron-catalysed formation of ascorbate radical.   
It has been suggested that, at neutral pH,  AscH- undergoes oxidation synergised by iron  
(EAsc/AscH- = 174 mV) [94]. The ascorbate free radical (AFR) produced [40,95]  can transfer 
single electrons to the FOC.  Thus, excess AFR production promoted by iron accelerates 
ascorbate-dependent iron mobilization from ferritin.  Additionally, iron may also accelerate 
the rate of interaction between ascorbate radical and ferritin.   
Ascorbate radical is formed, slowly, by spontaneous oxidation of ascorbate (equation 11), or 
more rapidly with iron catalysis, (equations 9 and 10), or enzymatically by ascorbate oxidase.  
It is apparent from the above discussion that, in addition to superoxide radical and ascorbate, 
ascorbate radical, generated in the reaction with ferritin, also mobilizes ferritin iron.  
One electron transfers from ascorbate radical to ferritin iron  
Ascorbic acid oxidase in the presence of dioxygen oxidizes ascorbate to form AFR [3,34,47,96]  
(Figures 12A,12B).  Increased AFR production, by ascorbic acid oxidase or by reaction of 
ascorbate with labile iron complexed with citrate [23,97]  increased the rate of iron 
mobilization from ferritin and both these processes reduced the apparent Km  (ascorbate) of 
ascorbate-dependent ferritin iron mobilization significantly (Figures 1B, 9B and S1A).  These 
processes were only partially inhibited by SOD.  The apparent Km  (ascorbate) obtained with 
ascorbic acid oxidase (0.59 ± 0.13 mM) (Figure 9B) is closer to that observed with ascorbate 
and iron and SOD (apparent Km  (ascorbate) = 0.25 ± 0.03 mM) (Figure 5B) and significantly lower 
than that observed without iron and with SOD (600 nM) (apparent Km  (ascorbate) = 1.8 ± 0.2 
mM) (P < 0.001) (Figure 5A), or without iron or SOD, apparent Km  (ascorbate) = 1.52 ± 0.52 mM (P 
< 0.05), (Figure 1C).   
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Both exogenous and endogenous hydrogen peroxide slow the rate of iron mobilization by one 
electron transfer from ascorbate, as is evident from   Figures 5C and 8B.   
The autoluminescence studies illustrated in Figure 10 revealingly show large differences 
between luminescence induced by ascorbate alone and in combination with FeSO4 (25 µM). 
The contrast between the very low autoluminescence signals of ferritin with ascorbate alone 
and the much higher chemiluminescence seen with ascorbate + iron indicates that in this 
latter case luminescence is mainly elicited by single electron transfers.  
The results observed with EPR methods corroborate the view that single electron transport 
from ascorbate radical occurs rapidly with ferritin (Figures 11A, 11B and 11D).   Also, that 
superoxide, ascorbate anion, and ascorbate radical all react with ferritin to promote iron 
reduction at the ferroxidase centre that lead to its mobilization.  It is evident that hydrogen 
peroxide suppresses iron mobilization both from direct inhibitory effects following exogenous 
addition of hydrogen peroxide and from the increased mobilization rates observed with 
catalase. 
As well as being a promoter of ascorbate radical generation (Figure 11A), ferritin evidently is 
an extremely effective promoter of ascorbate radical decay (Figures 12B and 12C) and as a 
hydrogen peroxide scavenger (Figure  5C) [98].    
Two electron transfer processes in relation to ferritin iron mobilization  
In addition to single electron transfer reactions, two electrons can be transferred from 
appropriate donors to acceptor sources [38,99–101]  Where hydrogen peroxide is used as a 
direct two-electron acceptor,  dual electron transfer reactions or bidentate reactions are 
viewed as an alternative means of oxidizing the vicinal di-ferrous ions within the FOC [100].  
This  circumvents intermediate ROS formation  [19]  Two electron transfer processes are used 
in other oxo-bridged di-iron complexes e.g. catalases [101–103].   
These reactions are dependent on either dioxygen or hydrogen peroxide as two electron 
oxidizing agents that bridge di-iron or di-copper complexes, as illustrated diagrammatically in 
the introductory graphic, Figure 6A, and Eq. 1 and are evidently obscured from 
chemiluminescence or EPR detection.   
The nature of ferritin’s chemiluminescent signal elicited by ascorbate and iron   
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During iron uptake by apoferritin a “blue” intermediate is formed with an absorption 
maximum at 625 nm. It has been suggested that a highly conserved tyrosine residue in the 
vicinity of the ferroxidase centre [104]   forms a tyrosine radical and  acts  as a one electron 
capacitor [105–107].  Tryptophan fluorescence is also activated by iron citrate uptake into 
soybean ferritin [[87].  No equivalent absorption or luminescence studies on ferritin  iron 
reduction and mobilization have been reported to date; however, during electrolysis or 
horseradish peroxidase-catalysed oxidation of tyrosine, a blue-green chemiluminescence 
signal at 490 nm [88]  similar to that observed here with ferritin in Figure 10B, was attributed 
to the formation of an exciplex between tyrosine cation radical Tyr.+ and superoxide, probably 
originating from compound III (Fe(III)····O2
.-):  [Tyr+ O2
-]*  hv (490 nm).   SOD quenched this 
reaction with horseradish peroxidase [108,109],  but catalase was ineffective.     It has been 
suggested that aromatic radicals in metalloproteins can act as intermediate staging posts in 
electron transfer reactions [12,88,107,110].  In the present study, SOD alone did not reduce 
the chemiluminescence signal and SOD + catalase enhanced the signal (Figure 10D) 
suggesting that   that ascorbate radical or an ascorbate iron citrate complex may activate the 
chemiluminescence signal.    
The biphasic nature of the chemiluminescence response to raised ascorbate with Fe(II) (25 
M) is consistent with the view that citrate-Fe(II)-Asc●- complex, rather than citrate-Fe(II)-
AscH- generates the chemiluminescence signal as higher AscH-concentrations may displace 
Asc-  from the complex   (Graphic, Figure 10C).    
The enhancement of the ferritin chemiluminescence signal by catalase Figure 11D, 
corroborates the deduction from the experiments that endogenous hydrogen peroxide 
stabilizes the diferric ions at the ferroxidase centre from reduction by ascorbate-dependent 
electron donation. Hence removal of this shield promotes both iron mobilization and electron 
transference between ascorbate ferritin iron within the ferroxidase centre and a neighbouring 
tyrosine group[88].  
 
The experimental support for the view that two-electron reductive reactions of iron 
mobilization from ferritin differ from   single-electron reactions is summarised as follows:  
 The apparent Km for ascorbate-dependent ferritin iron mobilization is eightfold higher 
and Vmax approximately fivefold lower in the absence of labile iron (Figures 1B and 1C). 
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 The pH sensitivity of iron mobilization in the presence of ascorbate is approximately 
fourfold lower with iron present than without iron (Figure   2A). This   suggests that two-
electron reductions are less proton-dependent than the one-electron transfer reactions 
[19]  (Figure 6A).    
 The activation energy Ea of iron mobilization with ascorbate alone is threefold higher 
than with iron present (Figure 2B). 
 The I.C.50 of hydrogen peroxide inhibition of ascorbate-dependent mobilization of 
ferritin iron is at least sevenfold lower with ascorbate alone than with iron present (P 
<0.01) (Figure 5C). 
 Catalase reduces the apparent Km of ascorbate-dependent mobilization by 
approximately 80%, both with iron absent (Figure 8A) or iron present (10 M) (Figure 
8B).  This indicates that endogenous hydrogen peroxide shields ferritin iron against 
reduction by ascorbate.   Even with catalase present, the ferritin iron mobilization 
apparent Km (ascorbate + Fe(II)) is much lower than the apparent Km  (ascorbate) (P< 0.0001).   
 Even high ascorbate concentrations (10 mM) generate a very low chemiluminescent 
signal of ferritin, whereas the maximal ferritin chemiluminescence signal with ascorbate 
(100 M) and iron (25 M) is twenty-fold higher than with ascorbate alone.    
 Labile iron (40 M) increases the ferritin-induced ascorbate radical EPR signal with 
ascorbate (250 M) by 400% (Figure 11C).  This  is mainly due to enhanced 
intramolecular formation of ascorbate radical within ferritin [21,27,111].    
The results reported here show a synergy between low concentrations of labile iron and 
ascorbate as reducing and mobilizing agents of iron from the ferritin core. This explains why 
ascorbate alone is not notably pro-oxidant [34].      
Raised levels of total iron have been detected in synovial tissue and fluid from patients with 
rheumatoid arthritis [112–115]  with EPR of ascorbate free radicals [49,113,116].   In 
inflammation and with cancer therapy  raised ascorbate levels can have a pro-oxidant effect 
[21,49,54,117–120].  This can be ascribed to interactions with metal ions and may also  relate 
to enhanced iron release from ferritin  [21,54,121,122].     
Since autocatalytic iron release  from ferritin by ascorbate  occurs within the 
pathophysiological concentration ranges of ascorbate and labile iron and is retarded by 
effective chelation therapy such as desferrioxamine [43,123]   or quercetin [56]  that are 
known to inactivate Fenton reactions, this therapeutic approach to treatment of 
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Supplementary Figure S1A Effect of varying FeSO4 concentration in citrate buffer (10 and 20 
mM) with MOPS (50 mM) at pH 7.0 on the rates of iron mobilization from ferritin (500 nM) 
with ascorbate (5 mM) at 24°C.  Apparent Km Fe = 3.4 ± 2.0 M with citrate (10 mM); apparent 
Km  Fe = 43 ± 15 M with citrate (20 mM) (P <0.025). B Simulated and EPR observed changes 
in ascorbate free radical (right Y scale) and simulated ascorbate concentration changes (left 
Y scale) in incubations of ascorbate with ascorbic acid oxidase with or without ferritin at 
24°C. Ascorbate (250 µM); Asc Ox (8 nM) (i.e. 1 unit ml-1); ferritin (0-200 nM); citrate (1 mM) 
pH 7.0. 
Supplementary Figure S2 Plots of time course of ascorbate radical decrease with ascorbic 
acid oxidase and varying ferritin at 24°C. Ascorbate (250 µM); Asc Ox (8 nM) (i.e. 1 unit ml-1); 
ferritin (0-500 nM); no FeSO4; citrate (1 mM) pH 7.0. Mono-exponential fits are overlaid on 
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Figure 1 Chemical reactions involved in ascorbate and iron induced redox cycling. Equation 
numbers refer to equations in text. A Effect of ferritin and labile iron on typical time courses 
monitoring the development of ferrous-ferrozine complex using absorption 
spectrophotometry at 550 nm at 24°C. Ascorbate (10 mM), ferritin 0-50 nM; FeSO4 0-2.5 µM; 
ferrozine (75 µM); citrate (10 mM); MOPS (50 mM); pH 7.0. Each plotted point is the average 
of triplicate readings, the errors on each point are too small to be plotted. Rates of ferritin 
iron mobilization, calibrated to nmole mg-1 ferritin min-1, are derived from the difference 
between the slopes of linear regression analysis with and without ferritin. B Effects of varying 
ascorbate and FeSO4 concentration on the rate of iron(II) release from ferritin at 24°C as 
determined from ferrozine absorption changes. Ascorbate 0-10 mM, ferritin (50 nM); FeSO4 
0-10 µM; ferrozine (75 µM); citrate (10 mM); MOPS (50 mM); pH 7.0. Values are mean  
S.E.M. of triplicate experiments. C Effect of FeSO4 concentration on apparent Km  and Vmax 
values of ascorbate-dependent release of Fe(II) from ferritin. Values are mean  S.E.M. of 
triplicate experiments. Raising labile iron from 0 to 10 µM results in a hyperbolic decrease in 
apparent Km  ascorbate from 1.5 mM to approximately 200 µM (broken line, open squares); 
(apparent Km  Fe 0.8 ± 0.2 µM). The Vmax of ascorbate-dependent iron mobilization from 
ferritin increases exponentially with labile iron (continuous line, open circles).  
Figure 2A Effects of altering pH on ascorbate-dependent release of Fe(II) from ferritin at 
24°C as determined from ferrozine absorption changes. Ascorbate 0-10 mM, ferritin (50 nM); 
FeSO4 (0-10 µM); ferrozine (75 µM); citrate (10 mM); MOPS (50 mM) pH 5.5-8.5. There is 
negligible Fe(II) release when ascorbate is absent. The sensitivity of ascorbate-dependent iron 
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release to [H+] is enhanced in the presence of FeSO4 (10 M). Values are mean ± SEM, n= 4 
observations per point (P<0.01). B Arrhenius plots showing the rate of Fe(II) loss from 
ferritin; plotted as LogN(rates of Fe(II) release in moles iron (II) per mole ferritin and per 
second). Ascorbate (10 mM), ferritin (50 nM); FeSO4 (0-10 µM); citrate (10 mM); MOPS (50 
mM); pH 7.0. Temperatures were 4oC, 24oC and 37oC. Values are mean ± SEM, n= 6 
observations per point. There is a 3-fold decrease in activation energy (Ea) with ascorbate and 
10 M FeSO4 compared to Fe(II) absent. (P<0.01).  
Figure 3A Ferrozine absorbance changes following exposure of ferritin to varying FeSO4 
concentrations. Ascorbate (10 µM), ferritin (50 nM); FeSO4 (0.1-10 µM); ferrozine (75 µM); 
citrate (10 mM); MOPS (50 mM); pH 7.0. Each plotted point is the average of n = 4 readings, 
the errors on each point are too small to be plotted. Raising labile iron reduces the latency of 
iron mobilization to reach steady state.  B.  Effects of ascorbate and iron on the latency of 
iron mobilization from ferritin determined from ferrozine absorption changes. Ascorbate (10 
M - 5 mM); ferritin (50 nM); FeSO4 0.1-10 µM; ferrozine (75 µM); citrate (10 mM); MOPS (50 
mM); pH 7.0.  Two-way ANOVA shows independent effects of iron (P < 0.0001) and of 
ascorbate (P < 0.0001). C Effect of catalase on the initial release of iron(II) from ferritin 
measured by ferrozine absorption changes. Ascorbate (100 M); ferritin (50 nM); FeSO4 (10 
µM); catalase (0-10 nM); ferrozine (75 µM); citrate (10 mM); MOPS (50 mM); pH 7.0. Catalase 
raised the initial rate during the first 15 min (P < 0.001).  
Figure 4A Zn(II) inhibits ascorbate-dependent iron release from ferritin as determined from 
ferrozine absorption changes. Ascorbate (10 mM); ferritin (50 nM); ZnCl2 (0-10 M); 
no FeSO4; ferrozine (75 µM); citrate (10 mM); MOPS (50 mM); pH 7.0. Values are mean 
± SEM of 2 experiments, n = 6 replicates per point. Inhibition occurred in a 
concentration dependent manner.   Best fit hyperbolic regression line is shown   y = 
I.C.50. Vmax/(I.C.50 + [Zn]), with I.C.50 Zn(II) = 2,2  0,4 µM. B Zn(II) inhibits ascorbate + 
Fe(II) tandem iron mobilization from ferritin as determined from ferrozine absorption 
changes. Ascorbate (10 mM); ferritin (50 nM); ZnCl2 (0-20 M); FeSO4 (35 M); 
ferrozine (75 µM); citrate (10 mM); MOPS (50 mM); pH 7.0. Values are mean ± SEM of 
2 experiments, n = 6 replicates per point (p < 0.001). 
 
Figure 5 Influence of hydrogen peroxide on the rate of ascorbate-dependent iron release 
from horse spleen ferritin as determined from ferrozine absorption changes. Ferritin (50 
nM); ferrozine (75 µM); citrate (10 mM); MOPS (50 mM) pH 7.0. Values are mean ± SEM, n= 4 
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replicates per point. (A) Ascorbate (0-20 mM) and H2O2 (0-0.25 mM) were varied in the 
presence of SOD (600 nM, ie. 50 units.ml-1) alone. H2O2 non-competitively inhibits ascorbate-
dependent release in the absence of external Fe (II). (B) Ascorbate (0-20 mM) and H2O2 (0-1 
mM) were varied in the presence of SOD (120 nM, i.e. 10 units.ml-1) and FeSO4 (10 M). H2O2 
has a negligible effect on ascorbate-dependent release in the presence of both Fe (II) and 
SOD. (C) H2O2 (0-5 mM) and FeSO4 (0-5 M) were varied in the presence of SOD (120 nM) and 
ascorbate (10 mM). In the presence of increasing external Fe, Ki of H2O2 is increased from its 
initial value of 150 M, i.e. a reduction of H2O2 inhibition is observed (P < 0.001).   The Hill 
equation[128] was applied empirically to obtain line fits to the data in Figures 5A and 5B, 
where rate of iron release    
     [         ]  
           [         ]  
 ; where n is the Hill coefficient of 
ligand cooperativity. The fits and error estimates of the parameters were obtained using the 
Levenberg-Marquardt algorithm as outlined in Methods.  The fits in Figure 5C were obtained 
using the equation y =  
             
       [         ]
.  
Figure 6 A Proposed chemical structures involved in two electron transfers to the diferrous 
ferroxidase centre. Electron transfer from the diferrous ferroxidase centre to hydrogen 
peroxide, yielding an oxo-bridged diferric ferroxidase complex and avoiding hydroxyl radical 
production via the Fenton reaction as envisaged by Bou-Abdallah et al. [105], is shown in the 
upper panels and is mirrored in the lower panels by the reverse two-electron flow from 
ascorbate to the oxo-bridged diferric ferroxidase complex thus avoiding ascorbate radical 
formation.   B Chemical structures involved in one-electron transferences between 
ascorbate, ascorbate radical, and ferroxidase centre.  The graphic illustrates the sequential 
single electron processes between ascorbate and the di-ferric ferroxidase centre in which 
ascorbate radical is generated as an intermediate which may in turn reduce another ferric 
atom in a different ferroxidase centre of ferritin.  
 
 
Figure 7 A Effect of superoxide dismutase on labile iron-dependent iron release from ferritin 
as determined from ferrozine absorption changes. Ascorbate (10 mM); FeSO4 (0-10 µM); 
SOD (0-120 nM); ferritin (50 nM); ferrozine (75 µM); citrate (10 mM); MOPS (50 mM); pH 7.0. 
Values are mean ± SEM, n = 3 replicates per point. The rates of ferritin iron mobilization are 
expressed as   fractional value of the values without SOD. Increasing the external Fe(II) 
reduces the fractional inhibition of iron mobilization by SOD (120 nM) from 58% with zero 
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iron to 15% with FeSO4 10 M (P < 0.01).  B Effect of catalase on iron release from ferritin in 
the presence of ascorbate and FeSO4 as determined from ferrozine absorption changes. 
Ascorbate 250 µM; FeSO4 (0-10 µM); Catalase (5 nM; ferritin (50 nM); ferrozine (75 µM); 
citrate (10 mM); MOPS (50 mM) pH 7.0 (n= 8 for each condition). Catalase enhances 
ascorbate + iron tandem iron mobilization from ferritin (P < 0.01) but has no significant effect 
on ascorbate-dependent iron mobilization without iron.  C Effect of xanthine oxidase (XO) on 
iron mobilization in the presence of ascorbate and FeSO4 as determined from ferrozine 
absorption changes. Ascorbate (1 mM); FeSO4 (0-10 µM); xanthine (0.15 mM); XO (0-0.4 
milliunits mL-1); ferritin (50 nM); ferrozine (75 µM); citrate (10 mM); MOPS (50 mM) pH 7.0 
(n= 4 replicates per point). XO activity increased the rate of ascorbate-dependent iron release 
without labile iron by 100% (++ P < 0.01), but the rate of ascorbate + iron tandem iron release 
from ferritin only by 16% (***   P <0.001).  
Figure 8 A Effect of catalase on ascorbate-dependent iron mobilization from ferritin as 
determined from ferrozine absorption changes. Ascorbate 0-10 mM; no FeSO4; Cat (0-10 
nM); ferritin (50 nM); ferrozine (75 µM); citrate (10 mM); MOPS (50 mM); pH 7.0. The 
apparent Km  of ascorbate-dependent iron release decreases with addition of catalase (10 nM) 
from 1.20 ± 0.14 mM to 0.26 ± 0.03 mM (P< 0.0001), while Vmax increases from 9.80 ± 0.33  to 
10.9 ± 0.3 nmoles mg-1 ferritin min-1.B Effect of catalase on ascorbate + iron-dependent iron 
mobilization from ferritin as determined from ferrozine absorption changes. Ascorbate (0-
2.5 mM); FeSO4 (10 µM); Catalase (0-10 nM); ferritin (50 nM); ferrozine (75 µM); citrate (10 
mM); MOPS (50 mM) pH 7.0 (n= 12 per point two experiments). The apparent Km  of 
ascorbate + iron-dependent iron release decreases with addition of 10 nM catalase from 390 
± 31 M to 77.6 ± 10.5 M (P< 0.0001), while Vmax increases from 120 ±  4 to 125 ± 3 nmoles 
mg-1 ferritin min-1. 
Figure 9 A Effect of ascorbic acid oxidase (Asc Ox) in combination with SOD + Catalase on 
ascorbate-dependent iron mobilization from ferritin as determined from ferrozine 
absorption changes. Ascorbate (1 mM); SOD (0-120 nM); Catalase (0-5 nM); Asc Ox (0-2 nM); 
ferritin (50 nM); ferrozine (75 µM); citrate (10 mM); MOPS (50 mM) pH 7.0 (n= 8 replicates 
per condition).  Asc Ox increases ascorbate-dependent iron mobilization by ascorbate 1 mM. 
The effect of Asc Ox is significant with the enzyme at 2 nM (P < 0.05) and even at 1 nM (P < 
0.001) (not shown).  Asc Ox (2 nM)-dependent iron mobilization is unaffected by SOD (120 
nM) and catalase activity (10 nM) (P < 0.001).  B  Effect of ascorbic acid oxidase (Asc Ox) on 
ascorbate-dependent iron mobilization from ferritin as determined from ferrozine 
absorption changes. Ascorbate (0-2 mM); Asc Ox (0-1 nM); ferritin (50 nM); ferrozine (75 
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µM); citrate (10 mM); MOPS (50 mM); pH 7.0. Each point is average of two separate 
experiments (each point replicated 3-4 times). Asc Ox decreases the apparent Km ascorbate of 
iron mobilization from ferritin (P < 0.01). 
Figure 10 A Effect of ascorbate on scans of autochemiluminescence emission of ferritin at 
24°C. Autochemiluminescence of the incubation without ferritin was subtracted. Ascorbate 
(50-10000 µM); ferritin (500 nM); citrate (10 mM); MOPS (50 mM); pH 7.0. There is a small 
increase in luminescence with peak at 475 nm as ascorbate is increased from zero to 10 mM.  
B  Effect of ascorbate on scans of autochemiluminescence emission of ferritin in the 
presence of iron (II) at 24°C. Autochemiluminescence of the incubation without ferritin was 
subtracted. Ascorbate (25-1000 µM); ferritin (500 nM); FeSO4 (25 µM); citrate (10 mM); 
MOPS (50 mM); pH 7.0. The ascorbate-dependent increase in luminescence at 475 nm is 
larger in the presence of iron (II).C.  Luminescence of ferritin at 480 nm as a function of 
ascorbate with (broken line, open squares) or without (continuous line, open circles) 
addition of FeSO4 at  24°C. Autochemiluminescence of the incubation without ferritin was 
subtracted. Ascorbate 25-10000 µM; ferritin (500 nM); FeSO4 0-25 µM; citrate (10 mM); 
MOPS (50 mM); pH 7.0. D Comparison of effects of catalase, SOD, and catalase + SOD on the 
maximal luminescence emission of solutions of ferritin (500 nM), FeSO4 (25 µM), and 
ascorbate (250 µM) at 24°C. Citrate (10 mM); MOPS (50 mM); pH 7.0. Catalase (5 nM) or 
Catalase (5 nM) + SOD (120 nM) together increase autochemiluminescence, whereas SOD 
alone has no effect.  
Figure 11 A Comparison of EPR spectra of ascorbate radical observed in 1 mM citrate buffer 
at pH 7.0 and 24°C upon addition of ferritin (500 nM) on FeSO4 (10 M) + ascorbate (250 
M). B Comparison of EPR spectra of ascorbate radical observed in 1 mM citrate buffer at 
pH 7.0 and 24°C upon varying ascorbate from 0 to 1000 M in the presence of ferritin (500 
nM) + FeSO4 (20 µM). C. Effect of varying FeSO4 concentration on the ascorbate radical 
concentration measured by EPR in the presence of ferritin (500 nM) + ascorbate (250 M) at 
24˚C in citrate buffer (1 mM) at pH 7.0. There is a linear increase in AFR concentration with 
Fe(II). D Comparison of relative EPR signal of control {ascorbate (250 M), iron (20 M), 
ferritin (500 nM)} upon addition of SOD (600 nM) and deoxygenation at 24˚C in citrate (1 
mM) buffer at pH 7.0.  SOD reduces the ascorbate radical amplitude with ferritin by 58% and 
anoxia by 90 %.    E Effect of varying ascorbate on the ascorbate radical concentration 
measured by EPR in the presence of ferritin (500 nM) + FeSO4 (20 M) at 24˚C in 1 mM 
citrate buffer at pH 7.0.  Signal amplitude increases as a hyperbolic function of ascorbate. 
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Figure 12A    Effect of ascorbic acid oxidase on the time course of the ascorbate radical EPR 
signal decline at 24°C. Ascorbate 250 µM; Asc Ox (8 nM) (i.e. 1 unit ml-1); ferritin (200 nM); 
FeSO4 (20 µM); citrate (1 mM) pH 7.0. Each scan takes 21 s and is immediately followed by the 
next.   
Figure 12 B.  Plots of time course of ascorbate radical decrease with ascorbic acid oxidase 
with varying ferritin at 24°C. Ascorbate (250 µM); Asc Ox (8 nM) (i.e. 1 unit ml-1); ferritin (0-
500 nM); citrate (1 mM) pH 7.0. Experimental data (broken lines) are overlaid with mono-
exponential decay simulations (continuous lines). The lines are fitted to the reaction scheme 
provided in the supplementary information.C   Effect of varying ferritin on the pseudo-first 
order rate constant of ascorbate radical decrease at 24°C. Ascorbate (250 µM); Asc Ox (8 
nM) (i.e.1 unit ml-1); ferritin (0-500 nM); citrate (1 mM) pH 7.0. The rates of ascorbate radical 
decrease as a linear function of ferritin concentration. D Effect of varying FeSO4 
concentrations on the pseudo-first order rate constant of ascorbate radical decrease at 



































 Labile iron (LI) synergises ascorbate-dependent ferritin iron mobilization (ADFIM).  
 LI reduces the Km and increases the Vmax of ADFIM.  
 Catalase eradicates H2O2 shielding of ferritin’s ferroxidase centre from reducing 
agents.   
 ADFIM with LI is more pH sensitive and has a lower activation energy.     
 Ascorbate radical (AFR) generated by ascorbate oxidase increases ADFIM.   
 LI changes ADFIM from a slow dual to a fast bi-mono electron transfer reaction.    
 
